The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413
International Journal of Medicinal Chemistry · 2011
DOI: 10.1155/2011/424535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Medicinal Chemistry, 2011. Verfasst von Yvonne Connolly Martin. Beteiligte Einrichtung: Department of Global Pharmaceutical Research and Development, Martin Consulting, Waukegan, IL 60064, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The novel selective D1 dopaminergic full agonists A-68930, A-77636 were discovered by the synthesis of molecules to probe the bioactive conformation of the partial agonist SKF-38393, by the use of this information to add D1 affinity and selectivity to a screening hit, and by traditional medicinal chemistry exploration of structure-activity relationships. The subsequent design of A-86929 and ABT-413 capitalized on these results, recently disclosed agonists, and traditional medicinal chemistry.
Autor:innen und Institutionen
- Department of Global Pharmaceutical Research and Development, Martin Consulting, Waukegan, IL 60064, USA.
Zitieren
APA
Martin, Y. C. (2011). The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry. https://doi.org/10.1155/2011/424535
Vancouver
Martin YC. The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry. 2011. doi:10.1155/2011/424535
BibTeX
@article{Martin2011,
author = {Martin, Yvonne Connolly},
title = {The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413},
journal = {International Journal of Medicinal Chemistry},
year = {2011},
doi = {10.1155/2011/424535}
}
EUVIMED